Skip to main content

Lindsay Dudfield, Executive Director and CEO of Jindalee Resources Limited, Executed MOU with POSCO Holdings For Joint Research At McDermitt Lithium Project

JINDALEE RESOURCES LIMITED  (ASX: JRL) (Jindalee, the Company) is an Australian exploration company with Tier 1 lithium deposits in its portfolio in the United States. The Company’s core goals are to discover world-class mineral deposits and generate shareholder wealth. The United States is one of the largest marketplaces for lithium demand, and Jindalee is a leading company committed to help meet future demand. The Company is focussing efforts into developing its McDermitt lithium deposit. Jindalee Resources was listed on the Australian Securities Exchange (ASX) on 11th July 2002 and raised AUD 2.70 million. Now, it is a pure-play United States lithium company. Jindalee’s Projects: In June 2018, the Company acquired McDermitt and Clayton North, two lithium sediment projects in the United States. Both projects are 100% owned by HiTech Minerals Inc., a wholly owned, US-based subsidiary of Jindalee. Several factors attracted the Company’s interest in these projects including: Potenti...
Post a Comment

Carbonxt Group Limited And MD Mr Warren Murphy: Key Facts Regarding HY23 Results

 CARBONXT GROUP LIMITED (ASX: CG1) (Carbonxt, or the Company) has set its sights on building a new activated carbon facility in KENTUCKY, UNITED STATES. The Company has forged a strategic joint venture with Kentucky Coal Processing LLC to bring this plant to fruition. In the second quarter of FY 2023, the two companies will finish the engineering feasibility work for the new plant. The final legal documentation is set to conclude soon. This plant is estimated to enhance Carbonxt’s production capacity from ~16,000 TONNES TO OVER 25,000 (+57%). It would benefit the Company by decreasing pellet production costs and increasing margin growth. This project presents Carbonxt with an opportunity to leverage investments in pollution reduction technologies in the US market.

Updates on revenue

  • In 1H23, Cabonxt’s revenue stood at AUD 8.9 MILLION, which DECLINED 10% compared to AUD 9.9 MILLION in 1H22. Revenue dropped due to maintenance for new equipment installation at the Arden Hills and Black Birch manufacturing facilities.
  • Activated carbon pellets revenue was 23%, down from 1H22. This decline was due to scheduled downtime at the Arden Hills facility and a minor decrease in seasonal demand from the Company’s important AC pellets customer.
  • Revenue from Powdered Activated Carbon (PAC) increased by 6% compared to last year (1H22), primarily driven by higher volumes from the Company’s largest PAC customer. Carbonxt extended the contracts of all Powdered Activated Carbon (PAC) customers.
  • The gross margin for 1H23 is 28%, down from 36% in 1H22.
  • In 1H23, shipping and operating costs both rose compared to 1H22. A slight increase is noticed in operating costs (~ 2%), and shipping costs increased about 20% in 1H23 compared to 1H22. Shipping costs are 10.9% of sales compared to 1H22 at 8.2%.
Carbonxt Group Ltd: Financial Position

Carbonxt Group Ltd has a debt facility of AUD 5.5 MILLION from Pure Asset Management. During the Annual General Meeting held in November 2022, management approved another debt facility of AUD 15 MILLION with Pure Asset Management. The proceeds of AUD 9.5 MILLION will be used to fund the new facility in Kentucky after paying the existing debt facility of  AUD 5.5 MILLION that matures in April 2023. During 1H23, Carbonxt secured AUD 8.5 MILLION by issuing 85 million fully paid ordinary shares. The Company held AUD 6.2 million in cash and cash equivalents as of December 31st, 2022.

Resource Link



Labels:
Location: Canada

Comments

Post a Comment

Popular posts from this blog

VRX Silica Limited Is All Set For The Arrowsmith North Silica Sand Project: Signed Power LOI With ResourcesWA

  VRX SILICA LIMITED   (ASX: VRX) (VRX or Company) has signed a   LETTER OF INTENT (LOI)   with ResourcesWA, a company   SPECIALISING IN ENERGY AND MINING CONSULTING . The LOI aims to explore a potential power supply solution for their Arrowsmith North Silica Sand Project by directly utilising gas from a nearby wellhead. The  OBJECTIVE  of the LOI is to assess the feasibility of setting up a powerhouse equipped with containerised gas reciprocating engines at a nearby gas wellhead location. The powerhouse would be connected to the existing gas plant through a direct offtake and reticulation to the Arrowsmith North site through a dedicated transmission line. ResourcesWA has a team with ample resources and expertise in project development, delivery, and asset management. The LOI provides a detailed proposal description and reflects the parties’ intentions for  SIX MONTHS . The proposal incorporates all design, construction, and operational requiremen...
Post a Comment
Read more

Platina Resources Limited signed a Joint Venture agreement with Chalice Mining for the Mt Narryer Gold Project

  PLATINA RESOURCES LIMITED  (ASX: PGM) (Platina or the Company) is a mineral resource exploration company based in Western Australia. The Company has inked a  JOINT VENTURE AGREEMENT WITH CHALICE MINING LIMITED , a mineral exploration and development company, to operate the Mt Narryer Gold Project. Terms of the Joint Venture Stage 1 earn-in : Initially, Chalice Mining will earn a  51% INTEREST  in the project by investing  AUD 600,000  within two years, which must include at least  AUD 150,000  in the first year Stage 2 earn-in : Chalice Mining can acquire an additional  24% INTEREST  in the project by investing an extra  AUD 1.8 MILLION  within the next two years Platina free cost carry : Once Chalice Mining has obtained a  75% INTEREST  in the Project, Platina Resources Limited will continue to be free cost carried until the Pre-Feasibility Study is completed Contribute & Dilute : After the Pre-Feasibility...
Post a Comment
Read more

Roquefort Therapeutics and CEO Ajan Reginald: An Inspiring Story

Roquefort Therapeutic’s Portfolio The company’s portfolio includes four best-in-class programs, Midkine antibodies, Midkine RNA therapeutics, STAT-6 siRNA and MK cell therapy, built through the acquisition of Lyramid in 2020 and Oncogeni in 2022: Roquefort has two Midkine programs, developed and run by the acquired Lyramid team. Midkine, a heparin-binding protein, has long been known to be important in embryonic development. While barely detectable in healthy adults, Midkine is highly expressed during oncogenesis. MDK hinders the normal immune response to tumours and promotes metastatic spread to other organs, thereby contributing to various levels of cancer progression and reduced patient survival. Roquefort believes its know-how and patent strategy (the combination of the exclusive license and the efforts to patent in-house R&D) have established the entry barrier in targeting MDK. The patent strategy is focused on both the composition of matter patents and method patents for anti...
Post a Comment
Read more